Jersey’s government launched a 10-month pilot of automated medication dispensers in island homes on June 3, 2026, aiming to reduce missed doses and care staff visits for residents managing multiple prescriptions.
Jersey Pilots Smart Dispensers to Cut Medication Errors and Care Visits
An automated medication dispensing system has begun trials across Jersey, marking a step toward using digital health technology to improve medication adherence and reduce the burden on care staff. The pilot, backed by £77,500 in funding from Impact Jersey’s Innovation Programme, will deploy the devices in homes of residents who rely on multiple medications, manage long-term conditions, or need additional support from care providers.
The system, developed by Evondos in collaboration with local GPs, pharmacies, and care providers, dispenses medication at scheduled times and can monitor vital signs such as heart rate and blood oxygen levels. It also connects directly with care teams and pharmacies, enabling faster responses when support is needed. The pilot is designed to ensure accurate dosing, prevent unauthorized access, and alert care teams if doses are missed.
Why This Matters: Reducing Errors and Caregiver Burden
Jersey’s aging population and high prevalence of chronic conditions have placed increasing pressure on care services. The automated dispensers aim to address two key challenges: reducing missed or incorrect medication doses, which can lead to hospital readmissions, and cutting the need for multiple daily visits from care staff, which strains both providers and budgets.
According to Digital Jersey, the pilot will generate Jersey-specific data on clinical outcomes, workforce impact, and the cost-effectiveness of healthcare delivery. This evidence could inform broader adoption of the technology if the trial proves successful.
Nick Hucker, managing director of Evondos UK, emphasized the system’s dual purpose: “The pilot will explore how technology can improve medication safety while reducing pressure on care services. The system is designed to deliver medication accurately, prevent access outside scheduled times, and alert care teams if doses are missed.”
Hucker added that the technology is intended to help residents live more independently, a goal shared by local partners. Tony Moretta, CEO of Digital Jersey, called the pilot “a strong example of innovation being applied to a genuine everyday challenge.”
He noted that by bringing together healthcare providers, technology specialists, and local organizations, Jersey is testing solutions that could improve medication adherence, support care teams, and build a more sustainable healthcare system.
Who Benefits and What’s Next?
The pilot focuses on residents who take multiple medications, manage long-term conditions, or require additional support. The system’s ability to monitor vital signs and connect with care teams could also benefit those with fluctuating health needs, such as the elderly or individuals with chronic illnesses.
If the trial demonstrates success, the technology could be scaled up across Jersey or adapted for use in other regions facing similar healthcare challenges. The pilot’s findings will be closely watched by policymakers and healthcare providers, both in Jersey and beyond, as digital health solutions gain traction in managing chronic conditions and supporting independent living.
For now, the focus remains on gathering evidence. As Moretta noted, “Jersey has a real opportunity to use technology to support more independent living and improve health outcomes for islanders.”
The results of the pilot are expected to inform future decisions about the role of automated medication dispensers in the island’s healthcare system.
Broader Implications for Digital Health
Jersey’s pilot is part of a growing trend in digital health, where automated systems are being tested to improve medication management and reduce healthcare costs. Similar initiatives are underway in other regions, but Jersey’s approach—combining local partnerships, evidence gathering, and a focus on independent living—sets it apart.
As the pilot progresses, its outcomes will provide valuable insights into the real-world effectiveness of automated medication dispensers. If successful, the technology could become a model for other islands and communities seeking to leverage digital solutions to enhance care quality and efficiency.
The next 10 months will be critical in determining whether automated medication dispensers can deliver on their promise of safer, more efficient care. For now, Jersey is leading the way in testing how technology can transform everyday healthcare challenges into opportunities for better outcomes.
